查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1683387

全球肺支架市场 - 2025 至 2033 年

Global Lung Stents Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 159 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球肺支架市场规模达到 1.7557 亿美元，预计到 2033 年将达到 5.7998 亿美元，2025-2033 年预测期内的复合年增长率为 12.6%。

肺支架是一种用于维持因肺癌、气管支气管狭窄或慢性阻塞性肺病等疾病导致呼吸道阻塞或狭窄的患者气道通畅的医疗设备。这些管状植入物可防止气道塌陷并促进正常呼吸。它们由金属、硅胶或混合材料製成，具有灵活性、耐用性且易于拆卸。它们通常用于透过支气管镜进行的微创手术，缓解呼吸系统併发症并改善肺​​功能。

市场动态：

驱动因素与约束因素

呼吸系统疾病发生率上升

由于肺癌、慢性阻塞性肺病和气管支气管狭窄等呼吸系统疾病的增加，全球肺支架市场正在成长。这些情况会导致气道阻塞和呼吸困难，因此支架对于维持气道通畅和改善呼吸功能至关重要。人口老化、环境污染物和高吸烟率导致全球呼吸系统疾病病例激增。支架置入等微创治疗的需求正在推动市场扩张。支架材料的进步，包括药物洗脱支架和可生物降解支架，进一步提高了治疗效果。

例如，2020年，全球慢性阻塞性肺病盛行率为10.6%，病例数达4.8亿。到 2050 年，预计该数字将增加 1.12 亿，达到 5.92 亿，比 2020 年增加 23.3%。因此，呼吸系统疾病的增加确实增加了对肺支架的需求，这有助于预测期内整个市场的成长。

併发症和支架相关感染风险

肺支架儘管有其好处，但也存在支架移位、肉芽组织形成和感染等风险，这可能会阻碍其广泛应用。长时间放置支架可能会导致呼吸道刺激、阻塞或细菌感染，需要额外的医疗介入。支架移除和更换程序的复杂性增加了医疗专业人员的挑战。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按产品类型分类的片段
  • 材料片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第 3 章：动态

  • 影响因素
    • 驱动程式
      • 呼吸系统疾病发生率上升
      • 支架设计的技术进步
    • 限制
      • 併发症和支架相关感染风险
      • 有替代治疗方案可供选择
    • 机会
      • 新兴市场的扩张
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的既定领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 5 章：依产品类型

  • 气管支架
  • 支气管支架
  • 其他的

第 6 章：按材料

  • 金属支架
  • 硅胶支架
  • 混合支架

第 7 章：按最终用户

  • 医院
  • 门诊手术中心
  • 专科诊所
  • 其他的

第 8 章：区域市场分析与成长机会

  • 北美洲
    • 各区域重点动态
      • 我们
      • 加拿大
  • 欧洲
    • 各区域重点动态
      • 德国
      • 英国
      • 法国
      • 西班牙
      • 义大利
      • 欧洲其他地区
  • 拉丁美洲
    • 各区域重点动态
      • 墨西哥
      • 巴西
      • 阿根廷
      • 拉丁美洲其他地区
  • 亚太
    • 各区域重点动态
      • 中国
      • 印度
      • 日本
      • 韩国
      • 亚太其他地区
  • 中东和非洲
    • 各区域重点动态

第九章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第十章：公司简介

  • Boston Scientific Corporation
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 主要进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • Cook Medical
  • ELLA-CS, sro
  • Merit Medical Systems, Inc.
  • Novatech SA
  • Micro-Tech (Nanjing) Co., Ltd.
  • S&G Biotech Inc.
  • Medorah Meditek Pvt. Ltd
  • Mitrai Industries
  • E. Benson Hood Laboratories, Inc

第 11 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 12 章：附录

简介目录
Product Code: PH9326

The global lung stents market reached US$ 175.57 million in 2024 and is expected to reach US$ 579.98 million by 2033, growing at a CAGR of 12.6% during the forecast period 2025-2033.

Lung stents are medical devices used to maintain airway patency in patients with obstructed or narrowed airways due to conditions like lung cancer, tracheobronchial stenosis, or COPD. These tubular-shaped implants prevent airway collapse and facilitate normal breathing. Made from metal, silicone, or hybrid combinations, they offer flexibility, durability, and ease of removal. They are commonly used in minimally invasive procedures via bronchoscopy, providing relief for respiratory complications and improving lung function.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Respiratory Diseases

The global lung stents market is growing due to the rise in respiratory diseases like lung cancer, COPD and tracheobronchial stenosis. These conditions cause airway obstruction and breathing difficulties, making stents crucial for maintaining airway patency and improving respiratory function. The aging population, environmental pollutants, and high smoking rates contribute to the surge in respiratory cases worldwide. The demand for minimally invasive treatments like stent placements is boosting market expansion. Advancements in stent Material, including drug-eluting and biodegradable stents, further enhance treatment outcomes.

For instance, in 2020, COPD prevalence was 10.6% globally, resulting in 480 million cases. By 2050, it is projected to increase by 112 million to 592 million, a 23.3% increase from 2020 to 2050. This rise is primarily due to the rising COPD burden among females and in low- and middle-income countries (LMICs). Hence, the rise in the respiratory diseases indeed the need for lung stents demand are raised which helps the overall market to grow during the forecast period.

Complications and Risk of Stent-Related Infections

Lung stents, despite their benefits, carry risks like stent migration, granulation tissue formation and infections, which can hinder their widespread use. Prolonged stent placement can cause airway irritation, obstruction, or bacterial infections, necessitating additional medical intervention. The complexity of stent removal and replacement procedures adds to healthcare professionals' challenges.

Segment Analysis

The global lung stents market is segmented based on product type, material, end-user and region.

Product Type:

The tracheal stents from product type segment is expected to dominate the lung stents market

The tracheal stents holds is a significant position in the global lung stents market, providing life-saving solutions for patients with tracheal obstructions. These stents maintain airway patency, improving patient quality of life. Demand for tracheal stents is growing due to respiratory diseases and minimally invasive procedures. Innovations in stent materials, such as self-expanding metal and bioresorbable stents, have enhanced their effectiveness. Focusing on patient-specific customization and improved biocompatibility, tracheal stents drive market growth in emergency and long-term respiratory care.

For instance, in March 2022, Micro-Tech Endoscopy has introduced the first self-expanding tracheobronchial nitinol y-stent, the Y-Shaped Tracheal Stent System, designed for flexible and compliant treatment of malignant neoplasms at the tracheobronchial carina. Hence, the above solution helps for complex tracheobronchial obstructions, improving patient outcomes and procedural flexibility. This product also drives market growth by increasing the adoption of self-expanding nitinol stents in airway management.

Geographical Analysis

North America is expected to hold a significant position in the lung stents market with the highest market share

North America dominates the global lung stents market due to high prevalence of respiratory diseases like COPD and lung cancer, advanced healthcare infrastructure, increased healthcare spending, and widespread adoption of minimally invasive procedures. Strong research and development initiatives, favorable reimbursement policies, and the presence of leading medical device companies support market expansion. Government funding for respiratory disease management and technological advancements in stent designs further enhance treatment outcomes, making North America a dominant player in this sector.

Additionally, rise in number of product launches, approvals also drive this region to dominate during the forecast period. For instance, in October 2024, The FDA has approved a new stent designed to open airways in patients with growing cancers. The minimally invasive AMStent system, developed by Peytant Solutions, uses a metal frame encased in human amnion, a pliable membrane that forms the amniotic sac. Amnion has been used in various medical specialties for years, including treating chronic wounds, burns, and skin ulcers.

Competitive Landscape

The major global players in the lung stents market include Boston Scientific Corporation, Cook Medical, ELLA-CS, s.r.o, Merit Medical Systems, Inc., Novatech SA, Micro-Tech (Nanjing) Co., Ltd., S&G Biotech Inc., Medorah Meditek Pvt. Ltd, Mitrai Industries and E. Benson Hood Laboratories, Inc among others.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global lung stents market report delivers a detailed analysis with 70 key tables, more than 65 visually impactful figures and 159 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Material & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Material
  • 2.5. Snippet by End-User
  • 2.6. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Respiratory Diseases
      • 3.1.1.2. Technological Advancements in Stents Designs
    • 3.1.2. Restraints
      • 3.1.2.1. Complications and Risk of Stent-Related Infections
      • 3.1.2.2. Alternative Treatment Options Available
    • 3.1.3. Opportunity
      • 3.1.3.1. Expansion in Emerging Markets
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established Leaders with Largest Selling Brand
    • 4.1.3. Market Leaders with Established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Tracheal Stents*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Bronchial Stents
  • 5.4. Others

6. By Material

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 6.1.2. Market Attractiveness Index, By Material
  • 6.2. Metal Stents*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Silicone Stents
  • 6.4. Hybrid Stents

7. By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Hospitals*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Specialty Clinics
  • 7.5. Others

8. Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. Latin America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Mexico
      • 8.4.6.2. Brazil
      • 8.4.6.3. Argentina
      • 8.4.6.4. Rest of Latin America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. Boston Scientific Corporation*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue's
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals, etc.
    • 10.1.5. SWOT Analysis
  • 10.2. Cook Medical
  • 10.3. ELLA-CS, s.r.o.
  • 10.4. Merit Medical Systems, Inc.
  • 10.5. Novatech SA
  • 10.6. Micro-Tech (Nanjing) Co., Ltd.
  • 10.7. S&G Biotech Inc.
  • 10.8. Medorah Meditek Pvt. Ltd
  • 10.9. Mitrai Industries
  • 10.10. E. Benson Hood Laboratories, Inc

LIST NOT EXHAUSTIVE

11. Assumption and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us